MNMarion San Nicoló

Marion San Nicoló

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marion San Nicoló has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Alexander Berghaus

    Department of Otorhinolaryngology, Head and Neck Surgery, Ludwig Maximilian University of Munich, Marchioninistr. 15, 81377, Munich, Germany

    8 shared publications
  • Moritz Gröger

    Department of Otorhinolaryngology, Head and Neck Surgery, Ludwig-Maximilians-University of Munich, Munich, Germany

    4 shared publications
  • Donata Gellrich

    Department of Otorhinolaryngology, Head and Neck Surgery, Ludwig-Maximilians-University of Munich, Munich, Germany

    3 shared publications
  • Haneen Sadick

    Division of Facial Plastic Surgery, Department of Otorhinolaryngology, University of Mannheim, Mannheim, Germany

    3 shared publications
  • Katharina Eder

    Department of Otorhinolaryngology, Head and Neck Surgery, Ludwig-Maximilians-University of Munich, Munich, Germany

    3 shared publications
  • Klaus Stelter

    HNO Zentrum Mangfall-Inn, Rosenheim, Germany

    3 shared publications

Latest Publications

  • Open Access

    Molecular analysis of nasal secretion to identify Alzheimer’s disease

    by Marion San Nicoló, Hilary Wunderlich, Oliver Peters, Timo Grimmer, Lutz Frölich, Richard Metzler, Arno Schaepe, Sabine Mertzig, Klaus Hallermayer, Harald Waltenberger, et al.

    Background: Increasing clinical evidence shows significant drainage of cerebrospinal fluid (CSF) and its metabolites along the olfactory route into the nose. Nasal secretion‐based analysis of key Alzheimer biomarkers was compared to CSF‐based analysis in different cohorts.Method: We conducted a multicenter, prospective cohort study involving patients with cognitive impairment and availability of CSF measurement of the 4 AD‐specific proteins. Cohorts were defined based on CSF biomarker classification following NIA‐AA ATN research diagnostic framework and clinical findings. Nasal secretion (NS) was collected from the vicinity of the olfactory cleft. [NosetestAD] was performed for subsequent in vitro analysis.Result: For this analysis, 39 patients with cognitive impairment were included at 3 university clinics in Germany. The nasal sampling procedure [noseabsorb] is painless (VAS 2 ±1.7) and yields a high sample volume (mean 450 μl). [NosetestAD] allows for precise quantification in size and relative protein amount of AD biomarkers pTau181, total Tau, Amyloid‐ß1‐40 and Amyloid‐ß1‐42. By using an automated protein separation and immunodetection system, we are able to generate a protein specific biomarker signature for all 4 AD‐associated proteins (pTau, tTau, Aß42,Aß40) characterizing parameters such as oligomerization state and relative protein amount. Further, a highly significant discrimination of amyloid pathology (A+ vs. A‐) was achieved with an AUC of 0.94 and p‐value <0.001.Conclusion: Nasal secretion constitutes a safe, minimally invasive access to CSF. Therefore, it is highly suitable for detection and monitoring of AD relevant biomarkers. Within a cohort of patients with cognitive impairment A+ patients can be distinguished from A‐ patients based on their diseases state specific individual protein‐specific biomarker signatures and the different levels of oligomeric or monomeric structures. Thus, our proprietary diagnostic platform, detects and assesses a broad panel of brain derived biomarkers simultaneously and allows for intraindividual monitoring and possibly disease staging in nasal secretion.

  • Relevance of Major Allergens in Weed Pollen Allergy

    by Marion San Nicoló, Catalina Högerle, Donata Gellrich, Moritz Gröger

    Introduction: Weed pollen allergy is an important and in prevalence increasing cause of pollinosis in Europe and across the world. In this study we focus on the value of common diagnostic tools for detection of a sensitization to mugwort and English plantain, especially with regard to the clinical relevance of the sensitization. Methods: Eighty weed pollen sensitized patients (41 to mugwort and 39 to English plantain) were assessed retrospectively regarding their clinical anamnesis, in-vivo tests (skin prick test [SPT] and allergen specific provocation) and in-vitro tests (immunoglobulin E [IgE] reactivity to purified natural allergen extract and specific allergen components in serum). Results: 85% of mugwort and 83% of English plantain sensitizations could be diagnosed by SPT alone. Distinction between allergic and non-allergic patients could be made with clinical challenges solely. IgE serology revealed IgE antibodies against the native pollen extracts for mugwort in 98% and for English plantain in 90% of patients. Detection of major allergens nArt v 1, nArt v 3 and Pla l 1 did not add accuracy to the diagnosis. A vast majority of the weed pollen allergic patients was sensitized to >1 allergen. Minor allergens were found to be of less importance. Conclusion: The exact diagnosis of weed pollen allergy can be challenging due to confounding components in anamnesis and diagnostic tests. IgE-serology does not delineate allergic from sensitized patients. Component resolved diagnostics (CRD) can confirm, but not replace, extract based diagnostic methods, such as SPT, provocation tests or serology to native extracts. Hence, these are the gold standard diagnostic tools in weed pollen allergy up to now.


  • AERD Associated Nasal Polyposis: Efficacy of Postoperative Antileukotriene Therapy in Comparison with Aspirin Desensitization. A Retrospective Study

    by Marion San Nicoló, Nicole Habermann, Miriam Havel

    Introduction: AERD (aspirin-exacerbated respiratory disease) is a severe form of an inflammatory disease of the upper airway system. Therapy remains challenging due to a complex underlying pathophysiology. Objective: To evaluate the efficacy of postoperative antileukotriene therapy concerning recurrence of nasal polyposis in patients with AERD and to compare it with AD (aspirin desensitization) over time. Methods: In this retrospective study we analyzed AERD patients (N = 61) after functional endoscopic sinus surgery (FESS). Patients were treated at our institution postoperatively with topical mometasone (control group, N = 22), leukotriene-receptor-antagonists (montelukast [MT], N = 18) or underwent an aspirin desensitization (N = 21). Subjective parameters as assessed by SNOT (sinonasal outcome test) questionnaire and endoscopic endonasal examination (polyposis grading) were evaluated throughout a follow-up period of 6–9 and >12 (long-term) months after surgery. Results: Endoscopic endonasal examinations 6–9 months after sinus surgery showed a good disease control in all 3 groups with significant reduction in polyp grading in the AD group. After a follow-up period of more than 12 months, MT and AD patients had significantly less polyp recurrences as compared to the topical treatment group. Subjective sinonasal symptoms revealed that hyposmia and nasal obstruction were prominent factors in all 3 groups throughout the follow-up period. MT group showed significant improvement in sinonasal symptoms over time. Conclusion: Postoperative treatment with leukotriene-receptor-antagonists and aspirin desensitization both significantly reduce nasal polyp recurrence. MT has a positive effect on subjective sinonasal outcomes and patients’ quality of life over time.


  • Open Access

    Latera, minimal invasive Therapieoption zur Behandlung der Nasenklappeninstabilität mit einem resorbierbaren Implantat: Ein aktueller Überblick

    by M San Nicoló

    Einleitung Latera bietet eine neue Therapieoption zur minimal invasiven Behandlung der Nasenklappeninstabilität. Nach der ersten Studie, welche die Sicherheit und Wirksamkeit des Implantats bis zu 24 Monate nach Implantation untersucht hat, erfolgten weitere prospektive klinische Studien. Material und Methoden Metaanalyse bisher veröffentlichter Daten hinsichtlich der Sicherheit und Wirksamkeit des Implantats. Ergebnisse Bisher wurden insg. 434 Patienten an verschiedenen Zentren (EU, USA) in Studien eingeschlossen, welche das Implantat untersuchten. 30 Studienpatienten wurden nur mit dem Implantat versorgt, 101 Patienten erhielten das Implantat ± Septumplastik und/oder einer Turbinoplastik, 166 Patienten wurden ± Turbinoplastik in L.A. implantiert und 137 Patienten wurden Placebo-kontrolliert versorgt (71 Verum Gruppe, 66 Placebo Gruppe). Klinische Visiten fanden min. bis 3 Monate und max. bis 24 Monate nach der Implantation statt. Insgesamt zeigten die implantierten Patienten in allen Studien eine signifikante Reduktion des NOSE scores. 84 (11,9 %) unerwünschte Ereignisse waren in den Studien das Implantat betreffend, 38 Implantate (5,4 %) mussten entfernt werden. Sämtliche unerwünschte Ereignisse konnten ohne klinische Folgeschäden behoben werden. Schlussfolgerung/Diskussion Die bisher veröffentlichten Studien zeigen die Sicherheit und Wirksamkeit des Implantats in der alleinigen Anwendung sowie in Kombination mit nasenchirurgischen Eingriffen. Poster-PDF A-1695.PDF Publication Date: 10 June 2020 (online) © . © Georg Thieme Verlag KG Stuttgart · New York

  • The nasal valve: new insights on the static and dynamic NV with MR-imaging

    by Marion San Nicoló, Alexander Berghaus, Christian Jacobi, Ulrich Kisser, Mareike Haack, Wilhelm Flatz

    Purpose We assessed the static nasal valve angle with MR imaging in healthy subjects and evaluated the complex mechanism of nasal valve dynamics during physiologic and forced inspiration. Methods In 17 healthy subjects, measurements of the static nasal valve angle were conducted on MR scans, using a TSE Axial T2-weighted sequence and a 3 mm slice thickness. The dynamic changes of nasal valve movement were detected using MR Cine-imaging techniques. Results The static median angle of the nasal valve was found to be 28.6° with a range of 12.7°–39.3°. The median degree of nasal valve collapse during forced inspiration was 68% (range 20–99%) of the baseline (static nasal valve angle). In the moderately forced inspiration (3 s) the median nasal valve angle declined to 76% of the baseline angle (range 42–100%). In the physiologic or unforced inspiration, the median nasal valve angle was reduced to 86.3% of the baseline angle (range 52–100%). Conclusion MRI, as a non-invasive tool, is a reliable method for evaluation of the static nasal valve angle and for the illustration of the complex nasal valve dynamics.


  • The time course of nasal cytokine secretion in patients with aspirin-exacerbated respiratory disease (AERD) undergoing aspirin desensitization: preliminary data

    by Marion San Nicoló, Catalina Högerle, Donata Gellrich, Katharina Eder, Elisabeth Pfrogner, Moritz Gröger

    Aspirin-exacerbated respiratory disease (AERD) is a severe form of chronic rhinosinusitis with nasal polyps (CRSwNP) accompanied by asthma and an aspirin intolerance. The underlying pathomechanism of AERD still remains unclear, recent data suggest a complex inflammatory imbalance. In the present study, we investigated the cytokine patterns in AERD, CRSwNP and healthy control patients. Furthermore, we describe the change in cytokine level in the course of aspirin desensitization (AD) with continuous intake of aspirin.


  • Vorteile der Piezo-Technologie in der Rhinoplastik

    by M. San Nicoló, A. Berghaus

    In der plastischen und rekonstruktiven Gesichtschirurgie ist eine präzise, atraumatische Handhabung von Knorpel, Knochen und umliegendem Weichgewebe für das operative Ergebnis von besonderer Bedeutung. Die Piezo-Technologie („piezoelectric instrumentation“, PEI) bietet eine neue Möglichkeit des Gewebeerhalts und der sicheren und exakten Präparation und Schnittführung.


  • Open Access

    A 2-Year Follow-up Study of an Absorbable Implant to Treat Nasal Valve Collapse

    by Marion San Nicoló, Klaus Stelter, Haneen Sadick, Murat Bas, Alexander Berghaus

    The safety and effectiveness of an absorbable implant for lateral cartilage support have been recently demonstrated in subjects with nasal valve collapse (NVC) at 12 months postprocedure. This follow-up study aimed to assess whether the safety and effectiveness of the implant persist in these patients for 24 months after the procedure. Thirty subjects with Nasal Obstruction Symptom Evaluation (NOSE) score ≥ 55 and isolated NVC were treated; 14 cases were performed in an operating suite under general anesthesia and 16 cases were performed in a clinic-based setting under local anesthesia. The implant, a polylactic acid copolymer, was placed with a delivery tool within the nasal wall to provide lateral cartilage support. Subjects were followed up through 24 months postprocedure. Fifty-six implants were placed in 30 subjects. The mean preoperative NOSE score was 76.7 ± 14.8, with a range of 55 to 100. At 24 months, the mean score was 32.0 ± 29.3, reflecting an average within-patient reduction of −44.0 ± 31.1 points. There were no device-related adverse events in the 12 to 24 months period. There were five subjects who exited the study prior to the 24-month follow-up. Four of the five subjects who exited were elected for further intervention and one subject was lost to follow-up. This study demonstrates safety of an absorbable implant for lateral nasal wall support and symptom improvement in some subjects with NVC at 24 months postprocedure.


  • Open Access

    Two‐Year Sustained Benefit of an Absorbable Implant for the Treatment of NVC

    by Marion San Nicoló, Alexander Berghaus